Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sorting nexin-6 (SNX6) is a **member of the sorting nexin protein family** distinguished by a phosphoinositide-binding phox (PX) domain and a C-terminal coiled-coil (and in some cases BAR) domain [1][2][3][5]. **SNX6 is primarily involved in intracellular membrane trafficking**, functioning as part of the retromer complex, where it partners with other SNX proteins—most notably SNX1, SNX2, and SNX5—to mediate the retrograde transport of various cargo proteins from endosomes to the trans-Golgi network and in recycling to the plasma membrane [2][3][5]. This retromer activity is crucial for the correct localization and stability of select transmembrane proteins, including receptors for insulin, platelet-derived growth factor, epidermal growth factor, the leptin receptor, and members of the TGF-beta family [3]. Through these actions, SNX6 influences processes such as nutrient signaling, receptor recycling, and protein sorting for degradation, contributing to a range of cellular homeostatic and signaling functions. SNX6 is not a classical drug target (such as a receptor, enzyme, or channel) but plays a regulatory and scaffolding role essential for maintaining intracellular transport fidelity. Dysregulation or genetic aberration of SNX6 has been implicated in rare developmental diseases and, by analogy to related SNX proteins, may contribute to mechanisms underlying neurodegenerative disorders [2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sorting nexin-6 (SNX6).